Shedir Pharma Srl Unipersonale
MIL:SHE

Watchlist Manager
Shedir Pharma Srl Unipersonale Logo
Shedir Pharma Srl Unipersonale
MIL:SHE
Watchlist
Price: 4.86 EUR Market Closed
Market Cap: 55.2m EUR
Have any thoughts about
Shedir Pharma Srl Unipersonale?
Write Note

Shedir Pharma Srl Unipersonale
Total Other Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Shedir Pharma Srl Unipersonale
Total Other Income Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Other Income CAGR 3Y CAGR 5Y CAGR 10Y
Shedir Pharma Srl Unipersonale
MIL:SHE
Total Other Income
-€20k
CAGR 3-Years
-71%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Newron Pharmaceuticals SpA
SIX:NWRN
Total Other Income
€449k
CAGR 3-Years
4%
CAGR 5-Years
34%
CAGR 10-Years
N/A
Recordati Industria Chimica e Farmaceutica SpA
MIL:REC
Total Other Income
-€396k
CAGR 3-Years
-42%
CAGR 5-Years
43%
CAGR 10-Years
2%
P
Pierrel SpA
MIL:PRL
Total Other Income
-€132.7k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
18%
Friulchem SpA
MIL:FCM
Total Other Income
-€900.3k
CAGR 3-Years
-82%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Shedir Pharma Srl Unipersonale
Glance View

Market Cap
55.2m EUR
Industry
Pharmaceuticals

Shedir Pharma Group SpA operates as a holding company which engages in the research and development of nutraceuticals and medical devices. The company is headquartered in Mercato San Severino, Salerno and currently employs 71 full-time employees. The company went IPO on 2019-07-23. The firm markets its products in different forms and under the brand lines Shedir Farmaceutici, Deimos Farmaceutici, Phobos Farmaceutici, Menkar Farmaceutici and Greenplanet Divisione Farmaceutica. Its products cover a wide range of therapeutics areas, such as cardiovascular, dermatology, neurology, urology, gynecology and dental health, among others.

SHE Intrinsic Value
7.24 EUR
Undervaluation 33%
Intrinsic Value
Price

See Also

What is Shedir Pharma Srl Unipersonale's Total Other Income?
Total Other Income
-20k EUR

Based on the financial report for Dec 31, 2023, Shedir Pharma Srl Unipersonale's Total Other Income amounts to -20k EUR.

What is Shedir Pharma Srl Unipersonale's Total Other Income growth rate?
Total Other Income CAGR 3Y
-71%

Over the last year, the Total Other Income growth was -233%. The average annual Total Other Income growth rates for Shedir Pharma Srl Unipersonale have been -71% over the past three years .

Back to Top